TG Therapeutics Announces Outcome From Data Safety Monitoring Board Reviews Of UNITY-CLL And UNITY-NHL Clinical Trials; Board Identified No Safety Concerns And Recommended Trial Continue Without Modification
Benzinga Newsdesk